中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
1期
5-7
,共3页
穆艳顺%刘花玲%刘萍%宋冬梅%徐慧%郭兰芹
穆豔順%劉花玲%劉萍%宋鼕梅%徐慧%郭蘭芹
목염순%류화령%류평%송동매%서혜%곽란근
茵栀黄%蓝光%新生儿%高胆红素血症
茵梔黃%藍光%新生兒%高膽紅素血癥
인치황%람광%신생인%고담홍소혈증
Yinzhihuang%Blue light%Neonatal%Hyperbilirubinemia
目的:探讨茵栀黄联合蓝光治疗新生儿高胆红素血症的疗效。方法:将新生儿高胆红素血症80例分为治疗组(40例)和对照组(40例),对照组采用间隙蓝光照射,胆红素上升快或水平高者给予纠酸、肝酶诱导剂、白蛋白静脉滴注,对症及支持治疗,如供氧、抗感染、静脉营养、保持通便等常规治疗方法。治疗组在此基础上加用茵栀黄。两组治疗前查血清总胆红素,治疗期间,应用经皮胆红素监测仪,监测每天胆红素变化,同时监测血清胆红素值下降至正常的天数。结果:茵栀黄联合蓝光治疗组治疗前血清胆红素(310.60±20.53)μmol/L与对照组治疗前血清胆红素(298.37±17.13)μmol/L,比较两组无显著差异(P>0.05);茵栀黄联合蓝光治疗组治疗后胆红素值(78.52±14.59)μmol/L与对照组治疗后胆红素值(94.30±11.21)μmol/L比较两组差异有统计学意义(P<0.05);治疗组胆红素降至正常天数(5.32±2.37)d与对照组胆红素降至正常天数(7.12±2.33)d比较,两组差异均有统计学意义(P<0.05);茵栀黄联合蓝光治疗组总有效率90%,明显高于对照组总有效率75%,两组有效率差异有统计学意义(P<0.05)。结论:茵栀黄联合蓝光治疗新生儿高胆红素血症疗效肯定,值得临床推广。
目的:探討茵梔黃聯閤藍光治療新生兒高膽紅素血癥的療效。方法:將新生兒高膽紅素血癥80例分為治療組(40例)和對照組(40例),對照組採用間隙藍光照射,膽紅素上升快或水平高者給予糾痠、肝酶誘導劑、白蛋白靜脈滴註,對癥及支持治療,如供氧、抗感染、靜脈營養、保持通便等常規治療方法。治療組在此基礎上加用茵梔黃。兩組治療前查血清總膽紅素,治療期間,應用經皮膽紅素鑑測儀,鑑測每天膽紅素變化,同時鑑測血清膽紅素值下降至正常的天數。結果:茵梔黃聯閤藍光治療組治療前血清膽紅素(310.60±20.53)μmol/L與對照組治療前血清膽紅素(298.37±17.13)μmol/L,比較兩組無顯著差異(P>0.05);茵梔黃聯閤藍光治療組治療後膽紅素值(78.52±14.59)μmol/L與對照組治療後膽紅素值(94.30±11.21)μmol/L比較兩組差異有統計學意義(P<0.05);治療組膽紅素降至正常天數(5.32±2.37)d與對照組膽紅素降至正常天數(7.12±2.33)d比較,兩組差異均有統計學意義(P<0.05);茵梔黃聯閤藍光治療組總有效率90%,明顯高于對照組總有效率75%,兩組有效率差異有統計學意義(P<0.05)。結論:茵梔黃聯閤藍光治療新生兒高膽紅素血癥療效肯定,值得臨床推廣。
목적:탐토인치황연합람광치료신생인고담홍소혈증적료효。방법:장신생인고담홍소혈증80례분위치료조(40례)화대조조(40례),대조조채용간극람광조사,담홍소상승쾌혹수평고자급여규산、간매유도제、백단백정맥적주,대증급지지치료,여공양、항감염、정맥영양、보지통편등상규치료방법。치료조재차기출상가용인치황。량조치료전사혈청총담홍소,치료기간,응용경피담홍소감측의,감측매천담홍소변화,동시감측혈청담홍소치하강지정상적천수。결과:인치황연합람광치료조치료전혈청담홍소(310.60±20.53)μmol/L여대조조치료전혈청담홍소(298.37±17.13)μmol/L,비교량조무현저차이(P>0.05);인치황연합람광치료조치료후담홍소치(78.52±14.59)μmol/L여대조조치료후담홍소치(94.30±11.21)μmol/L비교량조차이유통계학의의(P<0.05);치료조담홍소강지정상천수(5.32±2.37)d여대조조담홍소강지정상천수(7.12±2.33)d비교,량조차이균유통계학의의(P<0.05);인치황연합람광치료조총유효솔90%,명현고우대조조총유효솔75%,량조유효솔차이유통계학의의(P<0.05)。결론:인치황연합람광치료신생인고담홍소혈증료효긍정,치득림상추엄。
Objective:To investigate efficacy of Yinzhihuang combined with blue light in the treatment of neonatal hyperbilirubinemia. Methods:80 cases of neonatal hyperbilirubinemia were divided into treatment group (40 cases) and control group (40 cases). The control group used the gap blue light irradiation, bilirubin increases fast or high level to give correct acid, Liver enzyme inducer, albumin infusion, symptomatic and supportive treatment, such as oxygen offering, resistance to infection, intravenous nutrition, keep laxative and other conventional treatment methods. The treated group was treated with Yinzhihuang based on the routine treatment. The two groups before treatment examination of the serum total bilirubin. During treatment, the application of percutaneous bilirubin monitor, monitoring daily bilirubin changes, while monitoring the serum bilirubin values decreased to normal days. Results: Before treatment, the treatment group examination of the serum bilirubin values was (310.60±20.53)μmol/L and the control group was (298.37±17.13)μmol/L, there were not significantly differences between the two groups (P>0.05). After treatment, treated group examination of serum bilirubin values was (78.52± 14.59)μmol/L and the control group was (94.30±11.21)μmol/L, the two group showed the statistically significant differences (P<0.05). The treated group bilirubin decreased to normal cost(5.32±2.37) days and the control group cost (7.12±2.33) days, the two group showed the statistically significant differences (P<0.05). The total efficiency of treated group was 90%, significantly higher than 75%of the control group, the differences of the total efficiency between two groups were statistically significant (P<0.05). Conclusion:Yinzhihuang combined with blue light has certain curative effect in the treatment of neonatal hyperbilirubinemia. It is worthy of clinical application.